Clinical trial
Bryostatin 1 in Treating Patients With Stage IV Breast Cancer
NCT00003205 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00003205 |
|---|---|
| Title | Bryostatin 1 in Treating Patients With Stage IV Breast Cancer |
| Official title | A Phase II Trial of Bryostatin-1 for the Treatment of Stage IV Breast Cancer |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | bryostatin 1 |
| Start date | Apr 1, 1998 |
| Primary completion | Apr 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | Apr 23, 2003 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: